NCI-H524 [H524] (ATCC® CRL-5831™) Organism: Homo sapiens, human / Tissue: lung; derived from metastatic site: lymph node / Disease: stage L,carcinoma; variant small cell lung cancer General Information Characteristics Culture Method Specifications History Documentation Print Email Share Share this product Facebook Twitter Google+ Permits and Restrictions View Permits View Restrictions Organism Homo sapiens, human Tissue lung; derived from metastatic site: lymph node Product Format frozen Culture Properties suspension Biosafety Level 1 Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. Disease stage L,carcinoma; variant small cell lung cancer Age 63 years Gender male Ethnicity Caucasian Derivation The line was established in November 1982. Clinical Data 63 years Caucasian male The patient received prior chemotherapy and radiation therapy. The patient was a smoker. Complete Growth Medium The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%. Cryopreservation Culture medium, 95%; DMSO, 5% Culture Conditions Temperature: 37°C STR Profile Amelogenin: XCSF1PO: 12D13S317: 12D16S539: 12D5S818: 12D7S820: 11,12THO1: 8,9.3TPOX: 8,10vWA: 14,17 Name of Depositor AF Gazdar, JD Minna Year of Origin 1982 References NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996. Permits These permits may be required for shipping this product: Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment. Basic Documentation Product Sheet Certificate of Analysis SDS Restrictions The line is available with the following restrictions: This cell line was deposited at the ATCC by Dr. Adi F. Gazdar and is provided for research purposes only. Neither the cell line nor products derived from it may be sold or used for commercial purposes. Nor can the cells be distributed to third parties for purposes of sale, or producing for sale, cells or their products. The cells are provided as service to the research community. They are provided without warranty of merchantability or fitness for a particular purpose or any other warranty, expressed or implied. Any proposed commercial use of the these cells, or their products, must first be negotiated with the National Cancer Institute (NCI). For further information, please contact NCI’s Technology Transfer Center at NCI_TTC_Contact@mail.nih.gov or by phone at (240)-276-5514. References NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.